Literature DB >> 3373004

A method of obtaining, processing, and analyzing human intestinal secretions for antibody content.

M M Gaspari1, P T Brennan, S M Solomon, C O Elson.   

Abstract

Human intestinal secretions can be readily obtained using a commercially available intestinal lavage solution. Although such secretions contained abundant protease activity, significant loss of immunoglobulins was prevented by the addition of a mixture of protease inhibitors. The total content of IgA, IgM, and IgG antibody in secretions was measured using sandwich ELISA. In the secretions of ten normal volunteers IgA was most abundant (197 micrograms/ml +/- 103 SD) followed by IgM (12.5 micrograms/ml +/- 6.8 SD) and IgG (0.24 micrograms/ml +/- 0.04 SD). The IgA in secretions was predominantly secretory IgA as shown by sucrose density centrifugation. The effect of intestinal secretions on the sensitivity of the antigen-specific ELISA was tested by adding murine myeloma IgA anti-TNP added to samples of human secretions. IgA anti-TNP activity could be detected as low as 1 ng/ml, and there was no evidence of interference with the ELISA by other constituents in the secretions. Using these methods an antigen-specific secretory IgA anti-cholera toxin B subunit response in the secretions of volunteers given an oral B subunit vaccine was readily demonstrated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3373004     DOI: 10.1016/0022-1759(88)90086-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  18 in total

1.  Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.

Authors:  R Troncone; N Caputo; A Campanozzi; M Cucciardi; V Esposito; R Russo; B De Vizia; L Greco; S Cucchiara
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Appraisal of gut lavage in the study of intestinal humoral immunity.

Authors:  S O'Mahony; J R Barton; S Crichton; A Ferguson
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

3.  Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation.

Authors:  Alexandra Daley; Roger Randall; Michael Darsley; Naheed Choudhry; Nicola Thomas; Ian R Sanderson; Nick M Croft; Paul Kelly
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

4.  Smoking, humoral immunity, and ulcerative colitis.

Authors:  E D Srivastava; J R Barton; S O'Mahony; D I Phillips; G T Williams; N Matthews; A Ferguson; J Rhodes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

5.  Ageing compromises gastrointestinal mucosal immune response in the rhesus monkey.

Authors:  L D Taylor; C K Daniels; D L Schmucker
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

6.  Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis.

Authors:  J Kilhamn; H Brevinge; A M Svennerholm; M Jertborn
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

7.  Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans.

Authors:  A Kantele; M Häkkinen; Z Moldoveanu; A Lu; E Savilahti; R D Alvarez; S Michalek; J Mestecky
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Kinetics of local and systemic immune responses to an oral cholera vaccine given alone or together with acetylcysteine.

Authors:  J Kilhamn; M Jertborn; A M Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

9.  Gut immunoglobulin alpha anti-glycan binding profiles as a research tool for local disease detection.

Authors:  Joseph J Otto; Crystal L Daniels; Lindsay N Schambeau; Brittany N Williams; Jana M Rocker; Lewis K Pannell
Journal:  Glycoconj J       Date:  2018-06-09       Impact factor: 2.916

10.  Mucosal and Cellular Immune Responses to Norwalk Virus.

Authors:  Sasirekha Ramani; Frederick H Neill; Antone R Opekun; Mark A Gilger; David Y Graham; Mary K Estes; Robert L Atmar
Journal:  J Infect Dis       Date:  2015-01-29       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.